Bioquímica y Biología Molecular
Departamento
![Foto de Ángel](/img/nophoto.png)
Ángel
Ramírez Payer
Publicacións nas que colabora con Ángel Ramírez Payer (15)
2023
-
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia
Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539
2021
2020
-
Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer
International Journal of Molecular Sciences, Vol. 21, Núm. 10
2019
-
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
Haematologica, Vol. 104, Núm. 3, pp. 576-586
-
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling
Frontiers in Immunology, Vol. 10
2018
-
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Leukemia, Vol. 32, Núm. 3, pp. 645-653
-
Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
Frontiers in immunology, Vol. 9, pp. 2917
-
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 10, pp. 2318-2326
2017
-
Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia
OncoImmunology, Vol. 6, Núm. 10
2015
-
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 526, Núm. 7574, pp. 519-524
2014
-
Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease
PLoS ONE, Vol. 9, Núm. 10
-
Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
BioMed Research International, Vol. 2014
-
Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome
Blood, Vol. 123, Núm. 24, pp. 3790-3796
2013
-
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
Leukemia, Vol. 27, Núm. 5, pp. 1100-1106